Leukemia
-
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Q&A
Pulling Back the Research Curtain
Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
Cracking the Code of Acute Myeloid Leukemia
Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
by Kendall K. Morgan
-
Forward Look
CAR T Cells for Blood Cancer Patients
Researchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
-
Survivor Profile
Breaking Down Barriers
Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
by Bradley Jones
-
More Data on COVID-19 Vaccination and Cancer
Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Chemobrain: It’s Not Your Imagination
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Searching the Blood for Signs of Altered Immunity
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
